Literature DB >> 1849153

Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays.

M N Bobrow1, K J Shaughnessy, G J Litt.   

Abstract

In a previous publication (Bobrow et al., J. Immunol. Methods (1989) 279-285), we described a novel signal amplification method, catalyzed reporter deposition (CARD), and its application to microplate immunoassays. The method utilizes the analyte-dependent reporter enzyme (ADRE) to catalyze the deposition of additional reporter onto the surface of a solid-phase immunoassay system. In this paper, we describe the utilization of CARD amplification for nonradiometric membrane assays where detection is facilitated by the formation of an insoluble chromogenic product. In the examples described, deposition of reporter is accomplished in two steps: (i) a horseradish peroxidase (HRP) ADRE catalyzes the deposition of either a biotin or fluorescein labeled phenol, and (ii) incubation with either enzyme labeled streptavidin or anti-fluorescein, respectively, results in the deposition of additional enzyme. Using this method, we have improved detection limits from 8- to greater than 200-fold depending on the amplification format and the chromogen used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849153     DOI: 10.1016/0022-1759(91)90399-z

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  40 in total

1.  Matching gene activity with physiological functions.

Authors:  Wei Huang; Yuh-Pyng Sher; Konan Peck; Yuan Cheng B Fung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus.

Authors:  I Zehbe; G W Hacker; H Su; C Hauser-Kronberger; J F Hainfeld; R Tubbs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Sensitive CSF ELISAs for the detection of MBL, MASP-2 and functional MBL/MASP-2.

Authors:  Janet Y Kwok; Ryan M Augst; Denise Y Yu; Kumud K Singh
Journal:  J Neurosci Methods       Date:  2012-06-21       Impact factor: 2.390

4.  Improved sensitivity of whole-cell hybridization by the combination of horseradish peroxidase-labeled oligonucleotides and tyramide signal amplification.

Authors:  W Schönhuber; B Fuchs; S Juretschko; R Amann
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

Review 5.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

6.  Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.

Authors:  F R Fusco; Q Chen; W J Lamoreaux; G Figueredo-Cardenas; Y Jiao; J A Coffman; D J Surmeier; M G Honig; L R Carlock; A Reiner
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 7.  In cell amplification.

Authors:  V Uhlmann; I Silva; K Luttich; S Picton; J J O'Leary
Journal:  Mol Pathol       Date:  1998-06

Review 8.  Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, 'who is still afraid of red, green and blue?'.

Authors:  E J Speel; F C Ramaekers; A H Hopman
Journal:  Histochem J       Date:  1995-11

9.  Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ.

Authors:  William A Day; Mark R Lefever; Robert L Ochs; Anne Pedata; Lauren J Behman; Julia Ashworth-Sharpe; Donald D Johnson; Eric J May; James G Grille; Esteban A Roberts; Jerry W Kosmeder; Larry E Morrison
Journal:  Lab Invest       Date:  2016-11-21       Impact factor: 5.662

10.  EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.

Authors:  Maria I Toki; Daniel E Carvajal-Hausdorf; Mehmet Altan; Joseph McLaughlin; Brian Henick; Kurt A Schalper; Konstantinos N Syrigos; David L Rimm
Journal:  J Thorac Oncol       Date:  2016-07-20       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.